The partnership will integrate Molecular Health’s digital drug development platform into Axxam's integrated early drug ...

Artificial intelligence and robotics are revolutionizing drug discovery by automating laboratory processes and enabling rapid ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

Pairing data-driven clinical-molecular insights with biological validation to identify relevant drug targets and confirm ...

Over the past year, drug discovery has gotten a massive boost from the CAS BioFinder Discovery Platform, which allows ...

High-level data curation/integration and methodology development from various drug discovery disciplines would be needed for accurate prediction of polypharmacology prediction and rational design ...

Recursion Pharmaceuticals RXRX and Schrodinger SDGR are pioneering the use of artificial intelligence (AI) in drug discovery ...

A Hong Kong University of Science and Technology (HKUST) research team has developed a catalytic enantioselective type II ...

Collaboration combines Nuclera's eProtein Discovery System, which accelerates protein expression, purification and ...

Synthesis is at the heart of drug discovery and development. The industry has increasingly demanded higher quality clinical candidates and has sought to exploit less druggable biological targets.

The cell line development market is projected to grow at a CAGR of 3.9%, increasing from USD 3,392.5 Million in 2025 to ...

The RNA Targeting Small Molecule Drug Discovery Market is poised for growth, driven by demand for treatments targeting cancer ...